Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer pharmacogenetics.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2008

Marsh Sharon

Abstract excerpt

Cancer pharmacogenetics is a burgeoning field. There are now many published associations between genotype and outcome or toxicity from chemotherapy treatment. Performing pharmacogenetics studies in cancer requires careful consideration of the sample type to be used (germline vs tumor); the genotyping platform to be used (medium, low, or high throughput); and the analysis and reporting of associations and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenetics
Share to Research Design
Share to Treatment Outcome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Selection

Share to Antineoplastic Agents

Share to Databases, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasms

Source

Identifiers

PMID: 18370241
DOI: 10.1007/978-1-59745-205-2_15

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer pharmacogenetics.PMID 18370241Read ↗

Cancer pharmacogenetics: polymorphisms, pathways and beyond.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

Pharmacogenetics and cancer therapy.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapySemantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Cancer. Genotyping treatments.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Cancer pharmacogenomics: implications on ethnic diversity and drug response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.